Riboflavin intake potential beneficial role in CKD patients, indicates study
Riboflavin intake potentially benefits CKD patients, indicates a study published in Medicine.
Current studies have not clarified the relationship between riboflavin intake and all-cause mortality in patients with chronic kidney disease (CKD). This study aims to investigate whether there is an association between riboflavin intake and the risk of all-cause mortality in patients with CKD. This was a retrospective cohort study with data extracted from the National Health and Nutrition Examination Survey (NHANES).
The study used Cox regression analysis to calculate hazard ratio (HR) and 95% confidence interval (CI) to assess the association between riboflavin intake and risk of all-cause mortality. Subgroup analyses were performed regarding gender, CKD stage, hypertension, hyperlipidemia and cardiovascular disease (CVD). A total of 3750 patients were ultimately included in the analyses. After excluding potential confounders, lower riboflavin intake was associated with a higher risk of all-cause mortality (Q1: HR = 1.33, 95% CI: 1.05–1.69). A similar association was also found in patients at mild/moderate stage (HR = 1.32, 95% CI: 1.05–1.66), in females (HR = 1.35, 95% CI: 1.01–1.81), with hypertension (HR = 1.37, 95% CI: 1.07–1.75), CVD (HR = 1.48, 95% CI: 1.08–2.03), and dyslipidemia (HR = 1.29, 95% CI: 1.01–1.66). This study found an association between low riboflavin intake and a high risk of all-cause mortality, indicating a potential beneficial role of riboflavin in CKD patients.
Reference:
Ren, Xiaoxu MDa,b; Wang, Ronga; Liu, Fen MDb; Wang, Quanzhen MDb; Chen, Hairong MDb; Hou, Yunfeng MDb; Yu, Lifeng MDb; Liu, Xiangchun MDc; Jiang, Zhimingb,*. Association between riboflavin intake and the risk of all-cause mortality of patients with chronic kidney disease: A retrospective cohort study. Medicine 103(39):p e39417, September 27, 2024. | DOI: 10.1097/MD.0000000000039417
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.